LENZ Therapeutics (LENZ) Change in Cash (2020 - 2026)
LENZ Therapeutics (LENZ) reported Change in Cash of -$407000.0 for Q1 2026, down 114.11% year-over-year from $2.9 million in Q1 2025, and down 85.0% quarter-over-quarter from -$220000.0 in Q4 2025.
LENZ Therapeutics (LENZ) Change in Cash (2020 - 2026) Analysis & Trends
LENZ Therapeutics (LENZ) has 7 years of Change in Cash data on file, last reported at -$407000.0 in Q1 2026.
- Change in Cash for Q1 2026 came in at -$407000.0, down 114.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (up 100.91% YoY), and the FY2025 annual result was $4.9 million, up 133.0% from the prior year.
- Change in Cash fell to -$407000.0 in Q1 2026 per LENZ's latest filing, from -$220000.0 in the prior quarter.
- Over five years, Change in Cash peaked at $165.3 million in Q1 2024 and troughed at -$191.9 million in Q1 2022.
- A 5-year average of -$20.5 million and a median of -$12.3 million in 2025 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2023: Change in Cash sank 246.27% in 2022, then soared 136.67% in 2023.
- A 5-year view of Change in Cash shows it stood at -$8.7 million in 2022, then gained by 11.0% to -$7.7 million in 2023, then plunged by 170.99% to -$20.9 million in 2024, then surged by 98.95% to -$220000.0 in 2025, then tumbled by 85.0% to -$407000.0 in 2026.
- Business Quant data shows LENZ's Change in Cash at -$407000.0 in Q1 2026, -$220000.0 in Q4 2025, and -$12.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 623.00 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 417.10 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -45.97 Mn |
| 10 | LENZ Therapeutics | 192.19 Mn | 192.19 Mn | 825,000.00 | -407,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -407,000.00 |
| Dec 31, 2025 | -220,000.00 |
| Sep 30, 2025 | -12.32 Mn |
| Jun 30, 2025 | 14.57 Mn |
| Mar 31, 2025 | 2.88 Mn |
| Dec 31, 2024 | -20.89 Mn |
| Sep 30, 2024 | -42.99 Mn |
| Jun 30, 2024 | -116.32 Mn |
| Mar 31, 2024 | 165.33 Mn |
| Dec 31, 2023 | -7.71 Mn |
| Sep 30, 2023 | -31.57 Mn |
| Jun 30, 2023 | -40.40 Mn |
| Mar 31, 2023 | 70.38 Mn |
| Dec 31, 2022 | -8.66 Mn |
| Sep 30, 2022 | -18.78 Mn |
| Jun 30, 2022 | -109.90 Mn |
| Mar 31, 2022 | -191.91 Mn |
| Dec 31, 2021 | -16.26 Mn |
| Sep 30, 2021 | 12.84 Mn |
| Jun 30, 2021 | 204.95 Mn |